Please enable JavaScript to continue using this application.

Compare $NERV vs $TARA | Chartloom

Compare

$NERV vs $TARA

Minerva Neurosciences Inc · Protara Therapeutics Inc

NERV

Minerva Neurosciences Inc

TARA

Protara Therapeutics Inc

Compare $NERV vs $TARA

Comparing Minerva Neurosciences Inc and Protara Therapeutics Inc

NERVMinerva Neurosciences Inc

TARAProtara Therapeutics Inc

NERVMinerva Neurosciences Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-18.9%

52W performance

12.4%

FCF yield

-17.7%

TARAProtara Therapeutics Inc

Market cap

$155M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-48.8%

52W performance

-45.7%

FCF yield

-42.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NERV

TARA

Detailed metrics comparison

NERV

Minerva Neurosciences Inc

TARA

Protara Therapeutics Inc

Market Cap

NERV$148M

TARA$155M

Enterprise Value

NERV$184M

TARA$138M

Price

NERV$3.18

TARA$2.76

P/E Ratio

NERVN/A

TARAN/A

P/S Ratio

NERV0.00x

TARA0.00x

EV/Sales

NERV0.00x

TARA0.00x

EV/EBITDA

NERV28.95x

TARA0.00x

P/B Ratio

NERV19.58x

TARA0.99x

P/FCF Ratio

NERVN/A

TARAN/A

EV/FCF

NERV-7.01x

TARA-2.07x

PEG Ratio

NERVN/A

TARAN/A

Forward P/E (NTM)

NERVN/A

TARAN/A

Forward P/S (NTM)

NERVN/A

TARAN/A

Revenue (TTM)

NERV$0

TARA$0

Revenue Growth (YoY)

NERVN/A

TARAN/A

Forward Rev Growth

NERV534.2%

TARA5488.8%

Gross Margin (TTM)

NERV0.0%

TARA0.0%

Operating Margin (TTM)

NERV0.0%

TARA0.0%

EBITDA Margin (TTM)

NERV0.0%

TARA0.0%

Net Margin (TTM)

NERV0.0%

TARA0.0%

FCF Margin (TTM)

NERVN/A

TARAN/A

Net Income (TTM)

NERV$-395M

TARA$-70M

FCF (TTM)

NERV$-26M

TARA$-66M

EPS (TTM)

NERV-$5.00

TARA-$1.15

ROE (TTM)

NERV-16962.0%

TARA-4172.0%

ROA (TTM)

NERV-50048.0%

TARA-3878.0%

ROIC (TTM)

NERV-16962.0%

TARA-4172.0%

Cash

NERV$25M

TARA$17M

Debt

NERV$60M

TARA$0

Net Cash/Debt

NERV$-35M

TARA$17M

Current Ratio (TTM)

NERV20.14x

TARA10.97x

Quick Ratio (TTM)

NERV19.04x

TARA10.81x

Debt/Equity (TTM)

NERV0.00x

TARA0.00x

Debt/Assets (TTM)

NERV0.0%

TARA0.0%

Interest Coverage (TTM)

NERVN/A

TARAN/A

Net Debt/EBITDA (TTM)

NERV0.00x

TARA0.00x

Beta

NERV0.04

TARA1.54

52W Performance

NERV12.4%

TARA-45.7%

YTD Performance

NERV-18.9%

TARA-48.8%

% from 52W High

NERV-74.5%

TARA-64.8%

% from 52W Low

NERV42.1%

TARA9.8%

Asset Turnover (TTM)

NERV0.00x

TARA0.00x

FCF Yield (TTM)

NERV-17.7%

TARA-42.9%

Earnings Yield (TTM)

NERV-266.7%

TARA-45.2%

Dividend Yield (TTM)

NERVN/A

TARAN/A

Rule of 40

NERV0.0

TARA0.0

EV/GP/RG

NERVN/A

TARAN/A

Ticker research

View NERV research View TARA research

Metric	NERV Minerva Neurosciences Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$148M	$155M
Enterprise Value	$184M	$138M
Price	$3.18	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	28.95x	0.00x
P/B Ratio	19.58x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.01x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	534.2%	5488.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-395M	$-70M
FCF (TTM)	$-26M	$-66M
EPS (TTM)	-$5.00	-$1.15
ROE (TTM)	-16962.0%	-4172.0%
ROA (TTM)	-50048.0%	-3878.0%
ROIC (TTM)	-16962.0%	-4172.0%
Financial Health
Cash	$25M	$17M
Debt	$60M	$0
Net Cash/Debt	$-35M	$17M
Current Ratio (TTM)	20.14x	10.97x
Quick Ratio (TTM)	19.04x	10.81x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	1.54
52W Performance	12.4%	-45.7%
YTD Performance	-18.9%	-48.8%
% from 52W High	-74.5%	-64.8%
% from 52W Low	42.1%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-17.7%	-42.9%
Earnings Yield (TTM)	-266.7%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NERV research	View TARA research

Valuation

P/S Ratio

NERV

0.00x

TARA

0.00x

EV/FCF

NERV

-7.01x

TARA

-2.07x

Growth & revenue

Forward Revenue Growth

TARA

5488.8%

NERV

534.2%

Profitability & performance

Gross Margin

NERV

0.0%

TARA

0.0%

ROE

TARA

-4172.0%

NERV

-16962.0%

FCF Yield %

NERV

-17.7%

TARA

-42.9%

52-Week Performance

NERV

12.4%

TARA

-45.7%

Detailed metrics comparison

NERV

Minerva Neurosciences Inc

TARA

Protara Therapeutics Inc

Market Cap

NERV$148M

TARA$155M

Enterprise Value

NERV$184M

TARA$138M

Price

NERV$3.18

TARA$2.76

P/E Ratio

NERVN/A

TARAN/A

P/S Ratio

NERV0.00x

TARA0.00x

EV/Sales

NERV0.00x

TARA0.00x

EV/EBITDA

NERV28.95x

TARA0.00x

P/B Ratio

NERV19.58x

TARA0.99x

P/FCF Ratio

NERVN/A

TARAN/A

EV/FCF

NERV-7.01x

TARA-2.07x

PEG Ratio

NERVN/A

TARAN/A

Forward P/E (NTM)

NERVN/A

TARAN/A

Forward P/S (NTM)

NERVN/A

TARAN/A

Revenue (TTM)

NERV$0

TARA$0

Revenue Growth (YoY)

NERVN/A

TARAN/A

Forward Rev Growth

NERV534.2%

TARA5488.8%

Gross Margin (TTM)

NERV0.0%

TARA0.0%

Operating Margin (TTM)

NERV0.0%

TARA0.0%

EBITDA Margin (TTM)

NERV0.0%

TARA0.0%

Net Margin (TTM)

NERV0.0%

TARA0.0%

FCF Margin (TTM)

NERVN/A

TARAN/A

Net Income (TTM)

NERV$-395M

TARA$-70M

FCF (TTM)

NERV$-26M

TARA$-66M

EPS (TTM)

NERV-$5.00

TARA-$1.15

ROE (TTM)

NERV-16962.0%

TARA-4172.0%

ROA (TTM)

NERV-50048.0%

TARA-3878.0%

ROIC (TTM)

NERV-16962.0%

TARA-4172.0%

Cash

NERV$25M

TARA$17M

Debt

NERV$60M

TARA$0

Net Cash/Debt

NERV$-35M

TARA$17M

Current Ratio (TTM)

NERV20.14x

TARA10.97x

Quick Ratio (TTM)

NERV19.04x

TARA10.81x

Debt/Equity (TTM)

NERV0.00x

TARA0.00x

Debt/Assets (TTM)

NERV0.0%

TARA0.0%

Interest Coverage (TTM)

NERVN/A

TARAN/A

Net Debt/EBITDA (TTM)

NERV0.00x

TARA0.00x

Beta

NERV0.04

TARA1.54

52W Performance

NERV12.4%

TARA-45.7%

YTD Performance

NERV-18.9%

TARA-48.8%

% from 52W High

NERV-74.5%

TARA-64.8%

% from 52W Low

NERV42.1%

TARA9.8%

Asset Turnover (TTM)

NERV0.00x

TARA0.00x

FCF Yield (TTM)

NERV-17.7%

TARA-42.9%

Earnings Yield (TTM)

NERV-266.7%

TARA-45.2%

Dividend Yield (TTM)

NERVN/A

TARAN/A

Rule of 40

NERV0.0

TARA0.0

EV/GP/RG

NERVN/A

TARAN/A

Ticker research

View NERV research View TARA research

Metric	NERV Minerva Neurosciences Inc	TARA Protara Therapeutics Inc
Market & Valuation
Market Cap	$148M	$155M
Enterprise Value	$184M	$138M
Price	$3.18	$2.76
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	28.95x	0.00x
P/B Ratio	19.58x	0.99x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.01x	-2.07x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	534.2%	5488.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-395M	$-70M
FCF (TTM)	$-26M	$-66M
EPS (TTM)	-$5.00	-$1.15
ROE (TTM)	-16962.0%	-4172.0%
ROA (TTM)	-50048.0%	-3878.0%
ROIC (TTM)	-16962.0%	-4172.0%
Financial Health
Cash	$25M	$17M
Debt	$60M	$0
Net Cash/Debt	$-35M	$17M
Current Ratio (TTM)	20.14x	10.97x
Quick Ratio (TTM)	19.04x	10.81x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.04	1.54
52W Performance	12.4%	-45.7%
YTD Performance	-18.9%	-48.8%
% from 52W High	-74.5%	-64.8%
% from 52W Low	42.1%	9.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-17.7%	-42.9%
Earnings Yield (TTM)	-266.7%	-45.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View NERV research	View TARA research